N4P — N4 Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- £1.95m
- £0.66m
Annual cashflow statement for N4 Pharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2018 December 31st | C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.39 | -0.949 | -1.57 | -1.54 | -1.03 |
| Non-Cash Items | -0.026 | 0.007 | 0.006 | -0.282 | -0.14 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.072 | 0.138 | 0.181 | 0.054 | 0.341 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.34 | -0.804 | -1.38 | -1.77 | -0.828 |
| Other Investing Cash Flow Items | 0.028 | — | — | — | — |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | 0.028 | — | — | — | — |
| Financing Cash Flow Items | -0.001 | -0.001 | -0.002 | 0.001 | -0.09 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 0.783 | 0.977 | 3.97 | 0.001 | 0.964 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.533 | 0.173 | 2.59 | -1.77 | 0.136 |